{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:29Z","timestamp":1790959289563,"version":"4.1.0"},"reference-count":72,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health, Italy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a long-term neurodegenerative condition that leads to the deterioration of neurons and synapses in the cerebral cortex, resulting in severe dementia. AD is significantly more prevalent in postmenopausal women, suggesting a neuroprotective role for estrogen. Estrogen is now known to regulate a wide array of physiological functions in the body by interacting with three known estrogen receptors (ERs) and with the \u03b2-amyloid precursor protein, a key factor in AD pathogenesis. Recent experimental evidence indicates that new selective ER modulators and phytoestrogens may be promising treatments for AD for their neuroprotective and anti-apoptotic properties. These alternatives may offer fewer side effects compared to traditional hormone therapies, which are associated with risks such as cardiovascular diseases, cancer, and metabolic dysfunctions. This review sheds light on estrogen-based treatments that may help to partially prevent or control the neurodegenerative processes characteristic of AD, paving the way for further investigation in the development of estrogen-based treatments.<\/jats:p>","DOI":"10.3390\/ijms25169077","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:16:24Z","timestamp":1724649384000},"page":"9077","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Estrogen Receptors: A New Frontier in Alzheimer\u2019s Disease Therapy"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-1455","authenticated-orcid":false,"given":"Giovanni Luca","family":"Cipriano","sequence":"first","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Anchesi","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles","volume":"136","author":"Szczupak","year":"2013","journal-title":"Brain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40478-018-0563-8","article-title":"The presubiculum is preserved from neurodegenerative changes in Alzheimer\u2019s disease","volume":"6","author":"Murray","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer\u2019s Disease","volume":"19","author":"Yachnis","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/brain\/awaa406","article-title":"Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer\u2019s disease","volume":"144","author":"DeFelipe","year":"2021","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1007\/s12035-020-01911-8","article-title":"Estrogen Signaling in Alzheimer\u2019s Disease: Molecular Insights and Therapeutic Targets for Alzheimer\u2019s Dementia","volume":"57","author":"Uddin","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s Disease: Epidemiology and Clinical Progression","volume":"11","author":"Byrnes","year":"2022","journal-title":"Neurol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer\u2019s disease (MCI and dementia) in primary care: A review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J. Internal Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer\u2019s disease: An analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320484","article-title":"Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer\u2019s disease: A population-based cardiovascular risk factors, aging and dementia study","volume":"30","author":"Rusanen","year":"2010","journal-title":"Dement. Geriatr. Cognit. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaneurol.2022.0976","article-title":"Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US","volume":"79","author":"Nianogo","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sando, S.B., Melquist, S., Cannon, A., Hutton, M.L., Sletvold, O., Saltvedt, I., White, L.R., Lydersen, S., and Aasly, J.O. (2008). APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol., 8.","DOI":"10.1186\/1471-2377-8-9"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/bjsports-2021-104981","article-title":"Physical activity as a protective factor for dementia and Alzheimer\u2019s disease: Systematic review, meta-analysis and quality assessment of cohort and case\u2013control studies","volume":"56","author":"Kujala","year":"2022","journal-title":"Br. J. Sports Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1212\/WNL.0000000000008775","article-title":"Midlife obesity, related behavioral factors, and the risk of dementia in later life","volume":"94","author":"Beydoun","year":"2020","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1756285608100427","article-title":"The potential for estrogens in preventing Alzheimer\u2019s disease and vascular dementia","volume":"2","author":"Simpkins","year":"2009","journal-title":"Therap. Adv. Neurol. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.crvi.2017.08.001","article-title":"Gene expression profile of estrogen receptors alpha and beta in rat brain during aging and following high fat diet","volume":"340","author":"Scudiero","year":"2017","journal-title":"C. R. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.neurobiolaging.2005.04.003","article-title":"Expression of estrogen receptor (ER) alpha and beta in mouse cerebral cortex: Effect of age, sex and gonadal steroids","volume":"27","author":"Sharma","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/EBC20200162","article-title":"Estrogen receptors and the aging brain","volume":"65","author":"Maioli","year":"2021","journal-title":"Essays Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2010.09.069","article-title":"Estrogen and aging affect the synaptic distribution of estrogen receptor \u03b2-immunoreactivity in the CA1 region of female rat hippocampus","volume":"1379","author":"Waters","year":"2011","journal-title":"Brain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2005.06.073","article-title":"Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: A qualitative and quantitative study","volume":"1056","author":"Mehra","year":"2005","journal-title":"Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3233\/JAD-141875","article-title":"Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer\u2019s disease","volume":"43","author":"Lan","year":"2015","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1212\/WNL.0000000000206833","article-title":"Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease","volume":"100","author":"Oveisgharan","year":"2023","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1196\/annals.1286.006","article-title":"Estrogen receptor gene expression in relation to neuropsychiatric disorders","volume":"1007","author":"Ostlund","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_28","first-page":"3840","article-title":"Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERalpha mRNA","volume":"85","author":"Osterlund","year":"2000","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","article-title":"Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies","volume":"8","author":"Urdinguio","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"58R","DOI":"10.1203\/pdr.0b013e3180457635","article-title":"Epigenetic regulation of neural gene expression and neuronal function","volume":"61","author":"Feng","year":"2007","journal-title":"Pediatr. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1210\/en.2009-0955","article-title":"Epigenetic Regulation of Estrogen Receptor \u03b1 Gene Expression in the Mouse Cortex during Early Postnatal Development","volume":"151","author":"Westberry","year":"2010","journal-title":"Endocrinology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gong, Z., Yang, S., Wei, M., Vlantis, A.C., Chan, J.Y.K., van Hasselt, C.A., Li, D., Zeng, X., Xue, L., and Tong, M.C.F. (2022). The Isoforms of Estrogen Receptor Alpha and Beta in Thyroid Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.916804"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.gene.2006.12.030","article-title":"The complete nuclear estrogen receptor family in the rainbow trout: Discovery of the novel ERalpha2 and both ERbeta isoforms","volume":"392","author":"Nagler","year":"2007","journal-title":"Gene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"25832","DOI":"10.1074\/jbc.272.41.25832","article-title":"Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha","volume":"272","author":"Pace","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): Subtype-selective ligands and clinical potential","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/mi.10.3.3","article-title":"A new class of estrogen receptor beta-selective activators","volume":"10","author":"Lo","year":"2010","journal-title":"Mol. Interv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10409230290771438","article-title":"Biological role of estrogen and estrogen receptors","volume":"37","author":"Nilsson","year":"2002","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Dama, A., Baggio, C., Boscaro, C., Albiero, M., and Cignarella, A. (2021). Estrogen Receptor Functions and Pathways at the Vascular Immune Interface. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084254"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-11-177","article-title":"A network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effect","volume":"11","author":"Younesi","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/cns.12806","article-title":"Nuclear and membrane estrogen receptor antagonists induce similar mTORC2 activation-reversible changes in synaptic protein expression and actin polymerization in the mouse hippocampus","volume":"24","author":"Xing","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/acel.12366","article-title":"Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218\/PTPA pathway","volume":"14","author":"Xiong","year":"2015","journal-title":"Aging Cell"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wang, C., Zhang, F., Jiang, S., Siedlak, S.L., Shen, L., Perry, G., Wang, X., Tang, B., and Zhu, X. (2016). Estrogen receptor-\u03b1 is localized to neurofibrillary tangles in Alzheimer\u2019s disease. Sci. Rep., 6.","DOI":"10.1038\/srep20352"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mesa-Herrera, F., Mar\u00edn, R., Torrealba, E., Santos, G., and D\u00edaz, M. (2022). Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer\u2019s Disease Independent of Amyloid-\u03b2 Production and Tau Phosphorylation. Front. Mol. Neurosci., 15.","DOI":"10.3389\/fnmol.2022.879146"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of \u03b2-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chiu, M.J., Chen, T.F., Hu, C.J., Yan, S.H., Sun, Y., Liu, B.H., Chang, Y.T., Yang, C.C., and Yang, S.Y. (2020). Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer\u2019s disease\u2014A cross-validation study. Nanomed. Nanotechnol. Biol. Med, 28.","DOI":"10.1016\/j.nano.2020.102182"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wang, X.L., and Li, L. (2021). Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u2019s Disease. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02407-1"},{"key":"ref_47","first-page":"128","article-title":"Estrogen receptor \u03b1 splice variant TADDI in the human supraoptic nucleus: An effect on neuronal size and changes in pneumonia","volume":"42","author":"Ishunina","year":"2021","journal-title":"Neuro Endocrinol. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Iacobas, D.A., Iacobas, S., Nebieridze, N., Vel\u00ed\u0161ek, L., and Vel\u00ed\u0161kov\u00e1, J. (2018). Estrogen Protects Neurotransmission Transcriptome During Status Epilepticus. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00332"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Morelli, A., Sarchielli, E., Guarnieri, G., Coppi, E., Pantano, D., Comeglio, P., Nardiello, P., Pugliese, A.M., Ballerini, L., and Matucci, R. (2017). Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer\u2019s Disease. Front. Cell. Neurosci., 11.","DOI":"10.3389\/fncel.2017.00339"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2015.07.015","article-title":"Neurite outgrowth promoting effect of 17-\u03b2 estradiol is mediated through estrogen receptor alpha in an olfactory epithelium culture","volume":"1624","author":"Pooley","year":"2015","journal-title":"Brain Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Duong, P., Tenkorang, M.A.A., Trieu, J., McCuiston, C., Rybalchenko, N., and Cunningham, R.L. (2020). Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment. Biol. Sex Differ., 11.","DOI":"10.1186\/s13293-020-0283-1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2741\/s476","article-title":"Lipid raft ER signalosome malfunctions in menopause and Alzheimer\u2019s disease","volume":"9","author":"Ferrer","year":"2017","journal-title":"Front. Biosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hbm.25200","article-title":"Estrogen, brain structure, and cognition in postmenopausal women","volume":"42","author":"Boyle","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13041-023-01068-0","article-title":"Attenuation of estrogen and its receptors in the post-menopausal stage exacerbates dyslipidemia and leads to cognitive impairment","volume":"16","author":"Meng","year":"2023","journal-title":"Mol. Brain"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Du, Y.K., Xiao, Y., Zhong, S.M., Huang, Y.X., Chen, Q.W., Zhou, Y.Q., Guo, J.Y., and Yang, C. (2021). Study on the Mechanism of Acori Graminei Rhizoma in the Treatment of Alzheimer\u2019s Disease Based on Network Pharmacology and Molecular Docking. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/5418142"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e01610","DOI":"10.1002\/brb3.1610","article-title":"Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2020","journal-title":"Brain Behav."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhao, D.P., Lei, X., Wang, Y.Y., Xue, A., Zhao, C.Y., Xu, Y.M., Zhang, Y., Liu, G.L., Geng, F., and Xu, H.D. (2022). Sagacious confucius\u2019 pillow elixir ameliorates Dgalactose induced cognitive injury in mice via estrogenic effects and synaptic plasticity. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.971385"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11064-018-2481-3","article-title":"Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in A\u03b2(1-42)-Treated Rats","volume":"43","author":"Song","year":"2018","journal-title":"Neurochem. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2016.11.023","article-title":"Puerarin suppression of A\u03b2(1-42)-induced primary cortical neuron death is largely dependent on ER\u03b2","volume":"1657","author":"Li","year":"2017","journal-title":"Brain Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4103\/1673-5374.219049","article-title":"Calycosin improves cognitive function in a transgenic mouse model of Alzheimer\u2019s disease by activating the protein kinase C pathway","volume":"12","author":"Song","year":"2017","journal-title":"Neural Regener. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4103\/1673-5374.130063","article-title":"Geniposide, the component of the Chinese herbal formula Tongluojiunao, protects amyloid-\u03b2 peptide (1-42-mediated death of hippocampal neurons via the non-classical estrogen signaling pathway","volume":"9","author":"Li","year":"2014","journal-title":"Neural Regener. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7416419","DOI":"10.1155\/2019\/7416419","article-title":"Young Coconut Juice Reduces Some Histopathological Changes Associated with Alzheimer\u2019s Disease through the Modulation of Estrogen Receptors in Orchidectomized Rat Brains","volume":"2019","author":"Balit","year":"2019","journal-title":"J. Aging Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.bmc.2019.04.003","article-title":"Synthesis and characterization of hydrogen peroxide activated estrogen receptor beta ligands","volume":"27","author":"Park","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2018.02.046","article-title":"Chronic Amyloid \u03b2 Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3","volume":"405","author":"Fekete","year":"2019","journal-title":"Neuroscience"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jnc.14927","article-title":"Donepezil-induced oligodendrocyte differentiation is mediated through estrogen receptors","volume":"155","author":"Imamura","year":"2020","journal-title":"J. Neurochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/jpet.106.109504","article-title":"Estrogenic agonist activity of ICI 182780 (Faslodex) in hippocampal neurons: Implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile","volume":"319","author":"Zhao","year":"2006","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kwakowsky, A., Potapov, K., Kim, S., Peppercorn, K., Tate, W.P., and \u00c1brah\u00e1m, I.M. (2016). Treatment of beta amyloid 1-42 (A\u03b2(1-42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo. Sci. Rep., 6.","DOI":"10.1038\/srep21101"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s12640-020-00289-8","article-title":"Selective Targeting of Non-nuclear Estrogen Receptors with PaPE-1 as a New Treatment Strategy for Alzheimer\u2019s Disease","volume":"38","author":"Wnuk","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3233\/JAD-150756","article-title":"STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-\u03b2 Toxicity","volume":"51","author":"Gray","year":"2016","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2014.11.007","article-title":"17\u03b2-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration","volume":"282","author":"Ma","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuint.2011.04.006","article-title":"Aroclor1254 interferes with estrogen receptor-mediated neuroprotection against beta-amyloid toxicity in cholinergic SN56 cells","volume":"59","author":"Bang","year":"2011","journal-title":"Neurochem. Int."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Nohara, T., Tsuji, M., Oguchi, T., Momma, Y., Ohashi, H., Nagata, M., Ito, N., Yamamoto, K., Murakami, H., and Kiuchi, Y. (2023). Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in A\u03b2-Oligomer-Induced Neuronal Injury. Biomedicines, 11.","DOI":"10.3390\/biomedicines11082135"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9077\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:37Z","timestamp":1760110837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/9077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":72,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25169077"],"URL":"https:\/\/doi.org\/10.3390\/ijms25169077","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}